the DOJ subsequently "pursued a new drug protocol that could survive legal challenges through firms whose identities it has fought to keep hidden." Dispute Between DC, Congress Could Arise Over Looming Vote To Decriminalize Some Hallucinogenic Substances. The Wall Street Journal (7/11, Peterson, Subscription Publ